A Phase 1 Study of ADI-001, an Allogeneic CD20-Targeted γδ CAR T cell Therapy, in Adults with Autoimmune Disease

ADI-001 - Adicet Bio

https://www.asn-online.org/education/kidneyweek/2024/program-abstract.aspx?controlId=4156013

Ben L. Hsu1; Yining Ye1; Monica Moreno1; Gregory Vosganian1; Simona Costanzo1; Francesco Galimi1; Francesco Boin2; Laith Al-Rabadi3; Fotios Koumpouras4

Sep 23, 2024